Identifying delirium in Parkinson disease: A pilot study
Rachael A Lawson1,2, Sarah J Richardson1,2, Alison J Yarnall1,2,3
1Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
International Journal of Geriatric Psychiatry
|January 30, 2020
Summary
Delirium is common in hospitalized Parkinson disease (PD) patients, affecting over half during their stay. Early and frequent screening is crucial as delirium is often missed, impacting patient outcomes.
Area of Science:
- Neurology
- Geriatrics
- Psychiatry
Background:
- Parkinson disease (PD) patients face heightened risks for delirium, a condition often underestimated due to overlapping symptoms.
- Delirium, characterized by confusion and inattention, is prevalent in older adults and can lead to adverse outcomes.
Purpose of the Study:
- To determine the prevalence and incidence of delirium in hospitalized patients with Parkinson disease.
- To highlight the underdiagnosis of delirium in this vulnerable population.
Main Methods:
- Inpatients with Parkinson disease were assessed for delirium using DSM-5 criteria during a 4-month period.
- Prevalence was measured at a single visit, while incidence captured cases throughout the hospital stay via clinical vignettes and consensus methods.
Main Results:
- Delirium prevalence was 34.0%, with incident cases reaching 56.6% during hospitalization.
- Patients with delirium were older, had higher frailty scores, and experienced longer hospital stays.
- Delirium was documented in only 14.8% of cases, indicating significant under-recognition.
Conclusions:
- Delirium is highly prevalent and increases during hospitalization in Parkinson disease patients.
- Routine screening for delirium throughout the hospital stay is essential for timely diagnosis and management.
- Future research should focus on frequent evaluations to detect emergent delirium in PD inpatients.
Related Concept Videos
Parkinson's Disease: Treatment
878
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
878
Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K


